CONTEXTVISION AB (CONTX.OL) Stock Fundamental Analysis

OSL:CONTX • SE0014731154

3.3 NOK
-0.18 (-5.17%)
Last: Feb 20, 2026, 02:58 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

5

Taking everything into account, CONTX scores 5 out of 10 in our fundamental rating. CONTX was compared to 10 industry peers in the Health Care Technology industry. CONTX has an average financial health and profitability rating. CONTX does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • CONTX had positive earnings in the past year.
  • In the past year CONTX had a positive cash flow from operations.
  • Of the past 5 years CONTX 4 years were profitable.
  • Each year in the past 5 years CONTX had a positive operating cash flow.
CONTX.OL Yearly Net Income VS EBIT VS OCF VS FCFCONTX.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

1.2 Ratios

  • CONTX has a Return On Assets (3.07%) which is in line with its industry peers.
  • The Return On Equity of CONTX (3.95%) is comparable to the rest of the industry.
  • With a Return On Invested Capital value of 2.67%, CONTX is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
  • Measured over the past 3 years, the Average Return On Invested Capital for CONTX is significantly above the industry average of 8.41%.
  • The last Return On Invested Capital (2.67%) for CONTX is well below the 3 year average (36.72%), which needs to be investigated, but indicates that CONTX had better years and this may not be a problem.
Industry RankSector Rank
ROA 3.07%
ROE 3.95%
ROIC 2.67%
ROA(3y)26.09%
ROA(5y)16.55%
ROE(3y)37.17%
ROE(5y)21.28%
ROIC(3y)36.72%
ROIC(5y)47.42%
CONTX.OL Yearly ROA, ROE, ROICCONTX.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

1.3 Margins

  • CONTX has a Profit Margin of 3.17%. This is comparable to the rest of the industry: CONTX outperforms 50.00% of its industry peers.
  • In the last couple of years the Profit Margin of CONTX has grown nicely.
  • CONTX has a Operating Margin of 2.90%. This is in the lower half of the industry: CONTX underperforms 60.00% of its industry peers.
  • CONTX's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 97.62%, CONTX belongs to the top of the industry, outperforming 90.00% of the companies in the same industry.
  • In the last couple of years the Gross Margin of CONTX has remained more or less at the same level.
Industry RankSector Rank
OM 2.9%
PM (TTM) 3.17%
GM 97.62%
OM growth 3Y-20.47%
OM growth 5Y1.61%
PM growth 3YN/A
PM growth 5Y19.46%
GM growth 3Y-0.19%
GM growth 5Y-0.03%
CONTX.OL Yearly Profit, Operating, Gross MarginsCONTX.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80 100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CONTX is creating value.
  • Compared to 1 year ago, CONTX has about the same amount of shares outstanding.
  • The number of shares outstanding for CONTX remains at a similar level compared to 5 years ago.
  • The debt/assets ratio for CONTX is higher compared to a year ago.
CONTX.OL Yearly Shares OutstandingCONTX.OL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CONTX.OL Yearly Total Debt VS Total AssetsCONTX.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • The Debt to FCF ratio of CONTX is 5.01, which is a neutral value as it means it would take CONTX, 5.01 years of fcf income to pay off all of its debts.
  • CONTX has a Debt to FCF ratio (5.01) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.07 indicates that CONTX is not too dependend on debt financing.
  • CONTX has a better Debt to Equity ratio (0.07) than 70.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 5.01
Altman-Z N/A
ROIC/WACC0.3
WACC8.94%
CONTX.OL Yearly LT Debt VS Equity VS FCFCONTX.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

2.3 Liquidity

  • A Current Ratio of 4.79 indicates that CONTX has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 4.79, CONTX belongs to the top of the industry, outperforming 90.00% of the companies in the same industry.
  • A Quick Ratio of 4.70 indicates that CONTX has no problem at all paying its short term obligations.
  • CONTX has a Quick ratio of 4.70. This is amongst the best in the industry. CONTX outperforms 90.00% of its industry peers.
Industry RankSector Rank
Current Ratio 4.79
Quick Ratio 4.7
CONTX.OL Yearly Current Assets VS Current LiabilitesCONTX.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • CONTX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -83.70%.
  • Measured over the past years, CONTX shows a very strong growth in Earnings Per Share. The EPS has been growing by 27.26% on average per year.
  • CONTX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -13.08%.
  • CONTX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.51% yearly.
EPS 1Y (TTM)-83.7%
EPS 3YN/A
EPS 5Y27.26%
EPS Q2Q%-100%
Revenue 1Y (TTM)-13.08%
Revenue growth 3Y10.03%
Revenue growth 5Y6.51%
Sales Q2Q%-21.24%

3.2 Future

  • CONTX is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -7.44% yearly.
  • CONTX is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -1.43% yearly.
EPS Next Y-103.45%
EPS Next 2Y-38.41%
EPS Next 3Y-7.44%
EPS Next 5YN/A
Revenue Next Year-17.19%
Revenue Next 2Y-6.46%
Revenue Next 3Y-3.79%
Revenue Next 5Y-1.43%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CONTX.OL Yearly Revenue VS EstimatesCONTX.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 50M 100M
CONTX.OL Yearly EPS VS EstimatesCONTX.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.1 0.2 0.3 0.4 0.5

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 66.00, the valuation of CONTX can be described as expensive.
  • CONTX's Price/Earnings ratio is in line with the industry average.
  • CONTX is valuated expensively when we compare the Price/Earnings ratio to 26.99, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 27.67, which means the current valuation is very expensive for CONTX.
  • CONTX's Price/Forward Earnings ratio is in line with the industry average.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.06, CONTX is valued at the same level.
Industry RankSector Rank
PE 66
Fwd PE 27.67
CONTX.OL Price Earnings VS Forward Price EarningsCONTX.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as CONTX.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of CONTX indicates a slightly more expensive valuation: CONTX is more expensive than 60.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 145
EV/EBITDA 17.7
CONTX.OL Per share dataCONTX.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

  • CONTX has a very decent profitability rating, which may justify a higher PE ratio.
  • A cheap valuation may be justified as CONTX's earnings are expected to decrease with -7.44% in the coming years.
PEG (NY)N/A
PEG (5Y)2.42
EPS Next 2Y-38.41%
EPS Next 3Y-7.44%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. Dividend

5.1 Amount

  • CONTX has a Yearly Dividend Yield of 4.18%, which is a nice return.
  • CONTX's Dividend Yield is rather good when compared to the industry average which is at 2.02. CONTX pays more dividend than 90.00% of the companies in the same industry.
  • CONTX's Dividend Yield is rather good when compared to the S&P500 average which is at 1.85.
Industry RankSector Rank
Dividend Yield 4.18%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DP0%
EPS Next 2Y-38.41%
EPS Next 3Y-7.44%
CONTX.OL Yearly Income VS Free CF VS DividendCONTX.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

More info and screens

Find the best dividend stocksShow peers with best dividend

CONTEXTVISION AB

OSL:CONTX (2/20/2026, 2:58:59 PM)

3.3

-0.18 (-5.17%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-06
Earnings (Next)02-19
Inst Owners6.92%
Inst Owner ChangeN/A
Ins Owners24%
Ins Owner ChangeN/A
Market Cap255.32M
Revenue(TTM)112.76M
Net Income(TTM)3.58M
Analysts40
Price Target4.08 (23.64%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.18%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-100%
Min EPS beat(2)-100%
Max EPS beat(2)-100%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-13.52%
Min Revenue beat(2)-22.13%
Max Revenue beat(2)-4.91%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-20%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-11.52%
Valuation
Industry RankSector Rank
PE 66
Fwd PE 27.67
P/S 2.15
P/FCF 145
P/OCF 27.31
P/B 2.68
P/tB 2.76
EV/EBITDA 17.7
EPS(TTM)0.05
EY1.52%
EPS(NY)0.12
Fwd EY3.61%
FCF(TTM)0.02
FCFY0.69%
OCF(TTM)0.12
OCFY3.66%
SpS1.53
BVpS1.23
TBVpS1.2
PEG (NY)N/A
PEG (5Y)2.42
Graham Number1.18
Profitability
Industry RankSector Rank
ROA 3.07%
ROE 3.95%
ROCE 3.38%
ROIC 2.67%
ROICexc 8.83%
ROICexgc 9.67%
OM 2.9%
PM (TTM) 3.17%
GM 97.62%
FCFM 1.48%
ROA(3y)26.09%
ROA(5y)16.55%
ROE(3y)37.17%
ROE(5y)21.28%
ROIC(3y)36.72%
ROIC(5y)47.42%
ROICexc(3y)120.16%
ROICexc(5y)134.4%
ROICexgc(3y)169.64%
ROICexgc(5y)243.25%
ROCE(3y)46.47%
ROCE(5y)60.03%
ROICexgc growth 3Y-39.35%
ROICexgc growth 5Y-1.08%
ROICexc growth 3Y-26.11%
ROICexc growth 5Y14.23%
OM growth 3Y-20.47%
OM growth 5Y1.61%
PM growth 3YN/A
PM growth 5Y19.46%
GM growth 3Y-0.19%
GM growth 5Y-0.03%
F-Score5
Asset Turnover0.97
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 5.01
Debt/EBITDA 0.55
Cap/Depr 92.01%
Cap/Sales 6.39%
Interest Coverage 250
Cash Conversion 79.95%
Profit Quality 46.76%
Current Ratio 4.79
Quick Ratio 4.7
Altman-Z N/A
F-Score5
WACC8.94%
ROIC/WACC0.3
Cap/Depr(3y)55.3%
Cap/Depr(5y)58.55%
Cap/Sales(3y)3.81%
Cap/Sales(5y)5.04%
Profit Quality(3y)103.4%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-83.7%
EPS 3YN/A
EPS 5Y27.26%
EPS Q2Q%-100%
EPS Next Y-103.45%
EPS Next 2Y-38.41%
EPS Next 3Y-7.44%
EPS Next 5YN/A
Revenue 1Y (TTM)-13.08%
Revenue growth 3Y10.03%
Revenue growth 5Y6.51%
Sales Q2Q%-21.24%
Revenue Next Year-17.19%
Revenue Next 2Y-6.46%
Revenue Next 3Y-3.79%
Revenue Next 5Y-1.43%
EBIT growth 1Y-87.72%
EBIT growth 3Y-12.49%
EBIT growth 5Y8.23%
EBIT Next Year-25%
EBIT Next 3Y6.69%
EBIT Next 5YN/A
FCF growth 1Y-95.22%
FCF growth 3Y82.69%
FCF growth 5Y67.13%
OCF growth 1Y-79.63%
OCF growth 3Y51.49%
OCF growth 5Y5.6%

CONTEXTVISION AB / CONTX.OL FAQ

What is the ChartMill fundamental rating of CONTEXTVISION AB (CONTX.OL) stock?

ChartMill assigns a fundamental rating of 5 / 10 to CONTX.OL.


What is the valuation status for CONTX stock?

ChartMill assigns a valuation rating of 2 / 10 to CONTEXTVISION AB (CONTX.OL). This can be considered as Overvalued.


What is the profitability of CONTX stock?

CONTEXTVISION AB (CONTX.OL) has a profitability rating of 6 / 10.


What is the financial health of CONTEXTVISION AB (CONTX.OL) stock?

The financial health rating of CONTEXTVISION AB (CONTX.OL) is 6 / 10.


What is the expected EPS growth for CONTEXTVISION AB (CONTX.OL) stock?

The Earnings per Share (EPS) of CONTEXTVISION AB (CONTX.OL) is expected to decline by -103.45% in the next year.